J Reprod Immunol:卵巢反应差与接受体外受精的妇女血清维生素D水平和促炎免疫反应有关

2020-10-02 MedSci原创 MedSci原创

卵巢反应差(POR)限制了不孕症的治疗结局。一项回顾性横断面研究调查了POR是否与有体外受精和胚胎移植失败史的不孕妇女的血清25(OH)维生素D(VD)水平和促炎免疫反应有关,研究结果已在线发表于J

卵巢反应差(POR)限制了不孕症的治疗结局。一项回顾性横断面研究调查了POR是否与有体外受精和胚胎移植失败史的不孕妇女的血清25(OH)维生素D(VD)水平和促炎免疫反应有关,研究结果已在线发表于J Reprod Immunol。

研究共纳入了157名体外受精失败的女性,根据血清25(OH)VD水平和最近一个IVF周期的卵巢反应分为四组;低VD(LVD)与POR、LVD与正常卵巢反应(NOR)、正常VD(NVD)与POR、NVD与NOR。研究了血清25(OH)VD水平、细胞免疫和自身免疫以及代谢参数,包括同型半胱氨酸和质粒原激活物抑制剂-1。

 

结果显示,与其他组相比,POR-LVD的外周血CD5+NK细胞水平(%)和NK细胞毒性显著升高(P<0.05)。与NOR-LVD和POR-NVD相比,POR-LVD女性CD19+B和CD19+/5+B-1细胞水平明显升高(P<0.05)。POR-LVD的TNF-α/IL-10产生Th1/Th2细胞的比例明显高于POR-NVD和NOR-NVD(P<0.05)。POR-LVD的外周血同型半胱氨酸水平明显高于NOR-LVD和POR-NVD(P<0.05)。

 

综上所述,该研究结果表明,对于POR和LVD的女性,应考虑评估细胞和自身免疫异常以及同型半胱氨酸等代谢因素。VD和叶酸补充可以进一步探索作为免疫和代谢病因的POR的一种可能的治疗方案。

 

原始出处:

 

Li WuJean Alyxa Vendiola, et al., Poor ovarian response is associated with serum vitamin D levels and pro-inflammatory immune responses in women undergoing in-vitro fertilization. J Reprod Immunol. 2019 Nov;136:102617. doi: 10.1016/j.jri.2019.102617. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1690066, encodeId=b60a1690066a6, content=<a href='/topic/show?id=fb802e08724' target=_blank style='color:#2F92EE;'>#促炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27087, encryptionId=fb802e08724, topicName=促炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b3128951451, createdName=ms6127405442416114, createdTime=Sat Jul 17 07:33:38 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280232, encodeId=acae1280232a4, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539940, encodeId=9e8e153994026, content=<a href='/topic/show?id=98013806437' target=_blank style='color:#2F92EE;'>#受精#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38064, encryptionId=98013806437, topicName=受精)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072113156483, createdName=旅苦化文_212, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602309, encodeId=11eb160230956, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889769, encodeId=9dbd889e697a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201002/5aa27c3bf29b443db2e78a39c3ca26d1/a12141a09b0442ceba9776e067e409ae.jpg, createdBy=4b7a5421722, createdName=ms9000000501247386, createdTime=Fri Oct 02 23:15:00 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1690066, encodeId=b60a1690066a6, content=<a href='/topic/show?id=fb802e08724' target=_blank style='color:#2F92EE;'>#促炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27087, encryptionId=fb802e08724, topicName=促炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b3128951451, createdName=ms6127405442416114, createdTime=Sat Jul 17 07:33:38 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280232, encodeId=acae1280232a4, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539940, encodeId=9e8e153994026, content=<a href='/topic/show?id=98013806437' target=_blank style='color:#2F92EE;'>#受精#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38064, encryptionId=98013806437, topicName=受精)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072113156483, createdName=旅苦化文_212, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602309, encodeId=11eb160230956, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889769, encodeId=9dbd889e697a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201002/5aa27c3bf29b443db2e78a39c3ca26d1/a12141a09b0442ceba9776e067e409ae.jpg, createdBy=4b7a5421722, createdName=ms9000000501247386, createdTime=Fri Oct 02 23:15:00 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1690066, encodeId=b60a1690066a6, content=<a href='/topic/show?id=fb802e08724' target=_blank style='color:#2F92EE;'>#促炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27087, encryptionId=fb802e08724, topicName=促炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b3128951451, createdName=ms6127405442416114, createdTime=Sat Jul 17 07:33:38 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280232, encodeId=acae1280232a4, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539940, encodeId=9e8e153994026, content=<a href='/topic/show?id=98013806437' target=_blank style='color:#2F92EE;'>#受精#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38064, encryptionId=98013806437, topicName=受精)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072113156483, createdName=旅苦化文_212, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602309, encodeId=11eb160230956, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889769, encodeId=9dbd889e697a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201002/5aa27c3bf29b443db2e78a39c3ca26d1/a12141a09b0442ceba9776e067e409ae.jpg, createdBy=4b7a5421722, createdName=ms9000000501247386, createdTime=Fri Oct 02 23:15:00 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1690066, encodeId=b60a1690066a6, content=<a href='/topic/show?id=fb802e08724' target=_blank style='color:#2F92EE;'>#促炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27087, encryptionId=fb802e08724, topicName=促炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b3128951451, createdName=ms6127405442416114, createdTime=Sat Jul 17 07:33:38 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280232, encodeId=acae1280232a4, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539940, encodeId=9e8e153994026, content=<a href='/topic/show?id=98013806437' target=_blank style='color:#2F92EE;'>#受精#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38064, encryptionId=98013806437, topicName=受精)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072113156483, createdName=旅苦化文_212, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602309, encodeId=11eb160230956, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889769, encodeId=9dbd889e697a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201002/5aa27c3bf29b443db2e78a39c3ca26d1/a12141a09b0442ceba9776e067e409ae.jpg, createdBy=4b7a5421722, createdName=ms9000000501247386, createdTime=Fri Oct 02 23:15:00 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
    2020-10-04 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1690066, encodeId=b60a1690066a6, content=<a href='/topic/show?id=fb802e08724' target=_blank style='color:#2F92EE;'>#促炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27087, encryptionId=fb802e08724, topicName=促炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b3128951451, createdName=ms6127405442416114, createdTime=Sat Jul 17 07:33:38 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280232, encodeId=acae1280232a4, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539940, encodeId=9e8e153994026, content=<a href='/topic/show?id=98013806437' target=_blank style='color:#2F92EE;'>#受精#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38064, encryptionId=98013806437, topicName=受精)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=072113156483, createdName=旅苦化文_212, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602309, encodeId=11eb160230956, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Sun Oct 04 09:33:38 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889769, encodeId=9dbd889e697a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201002/5aa27c3bf29b443db2e78a39c3ca26d1/a12141a09b0442ceba9776e067e409ae.jpg, createdBy=4b7a5421722, createdName=ms9000000501247386, createdTime=Fri Oct 02 23:15:00 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
    2020-10-02 ms9000000501247386

    学到了

    0

相关资讯

《Science》热评:基因组编辑不是体外受精

“贺建奎谈到了IVF(体外受精)之父Robert Edward,他认为Edward是一个英雄,是一个突破规范的打破者,一个扰乱者,他希望能模仿他。这给我留下了深刻的印象。”

体外受精-胚胎移植后双侧输卵管异位妊娠1 例

患者,女, 31 岁, G3P0,因“胚胎移植后第32 天,阴道流血10+天”就诊于我院。患者9 年前有异位妊娠史,曾接受甲氨蝶呤 注射治疗, 1 年前有自发流产病史。患者 1 个月前于外院行体外受精胚胎移植,移植后第 12 天、第 14 天、第 21 天、第 24 天血 β-HCG 分别为 162mIU/ml、357mIU/ml、2547mIU/ml 及 2897mIU/ml。胚胎移植后第 26

Lancet:山东大学生殖医学原创研究成果——体外受精冷冻单个囊胚移植与新鲜单囊胚移植的比较

近日,山东大学陈子江教授团队的又一项全国多中心前瞻性随机对照临床研究,以原创研究文章形式在国际著名医学期刊《柳叶刀》杂志(影响因子:53.254)发表,题为“体外受精冷冻单个囊胚移植与新鲜单囊胚移植的比较” 。

NEJM:子宫内膜吸刮术与体外受精活产率

研究认为,子宫内膜吸刮术不能提高接受体外受精女性的新生儿活产率

PNAS:龙凤胎虽好,对女性不利

对于准妈妈而言,怀上龙凤胎简直就像中奖一样。然而,美国和挪威的研究人员近日却发现,龙凤胎中男性的睾酮会对他的双胞胎姐妹产生长期的影响。这项成果于本周发表在《美国科学院院刊》(PNAS)杂志上。

BMJ:冷冻囊胚移植vs新鲜囊胚移植对体外受精女性妊娠率的影响

对于经周期规律女性,接受促性腺激素释放激素激动剂诱导后,冷冻囊胚移植或新鲜囊胚移植之间的妊娠率和不良事件率无显著差异。